Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Ptc Therapeutics Stock Quote

Ptc Therapeutics (NASDAQ: PTCT)

Price as of July 16, 2024, 11:35 a.m. ET

Ptc Therapeutics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
PTCT -15.44% -22.65% -5.01% +101%
S&P +24.51% +86.32% +13.24% +254%

Ptc Therapeutics Company Info

PTC Therapeutics, Inc. is a biopharmaceutical company. It engages in discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

News & Analysis

The Fool has written over 100 articles on Ptc Therapeutics.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.